Literature DB >> 28069945

Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals.

Colin J McKinlay1, Jessica R Vargas1, Timothy R Blake1, Jonathan W Hardy2,3, Masamitsu Kanada2,3, Christopher H Contag4,3,5,6,7, Paul A Wender8,9, Robert M Waymouth8.   

Abstract

Functional delivery of mRNA to tissues in the body is key to implementing fundamentally new and potentially transformative strategies for vaccination, protein replacement therapy, and genome editing, collectively affecting approaches for the prevention, detection, and treatment of disease. Broadly applicable tools for the efficient delivery of mRNA into cultured cells would advance many areas of research, and effective and safe in vivo mRNA delivery could fundamentally transform clinical practice. Here we report the step-economical synthesis and evaluation of a tunable and effective class of synthetic biodegradable materials: charge-altering releasable transporters (CARTs) for mRNA delivery into cells. CARTs are structurally unique and operate through an unprecedented mechanism, serving initially as oligo(α-amino ester) cations that complex, protect, and deliver mRNA and then change physical properties through a degradative, charge-neutralizing intramolecular rearrangement, leading to intracellular release of functional mRNA and highly efficient protein translation. With demonstrated utility in both cultured cells and animals, this mRNA delivery technology should be broadly applicable to numerous research and therapeutic applications.

Entities:  

Keywords:  cell-penetrating; gene therapy; nanoparticle; organocatalysis; stimuli-responsive

Mesh:

Substances:

Year:  2017        PMID: 28069945      PMCID: PMC5278438          DOI: 10.1073/pnas.1614193114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

Review 1.  Liver gene therapy: advances and hurdles.

Authors:  T H Nguyen; N Ferry
Journal:  Gene Ther       Date:  2004-10       Impact factor: 5.250

2.  Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients.

Authors:  Susanne M Rittig; Maik Haentschel; Katrin J Weimer; Annkristin Heine; Martin R Muller; Wolfram Brugger; Marius S Horger; Olga Maksimovic; Arnulf Stenzl; Ingmar Hoerr; Hans-Georg Rammensee; Tobias A W Holderried; Lothar Kanz; Steve Pascolo; Peter Brossart
Journal:  Mol Ther       Date:  2010-12-28       Impact factor: 11.454

3.  Designed guanidinium-rich amphipathic oligocarbonate molecular transporters complex, deliver and release siRNA in cells.

Authors:  Erika I Geihe; Christina B Cooley; Jeff R Simon; Matthew K Kiesewetter; Justin A Edward; Robyn P Hickerson; Roger L Kaspar; James L Hedrick; Robert M Waymouth; Paul A Wender
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

4.  Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells.

Authors:  T Bettinger; R C Carlisle; M L Read; M Ogris; L W Seymour
Journal:  Nucleic Acids Res       Date:  2001-09-15       Impact factor: 16.971

5.  Modulated protonation of side chain aminoethylene repeats in N-substituted polyaspartamides promotes mRNA transfection.

Authors:  Hirokuni Uchida; Keiji Itaka; Takahiro Nomoto; Takehiko Ishii; Tomoya Suma; Masaru Ikegami; Kanjiro Miyata; Makoto Oba; Nobuhiro Nishiyama; Kazunori Kataoka
Journal:  J Am Chem Soc       Date:  2014-08-25       Impact factor: 15.419

Review 6.  Gene therapy for liver enzyme deficiencies: what have we learned from models for Crigler-Najjar and tyrosinemia?

Authors:  Tuan Huy Nguyen; Nicolas Ferry
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2007-10       Impact factor: 3.869

7.  The expression of exogenous genes in macrophages: obstacles and opportunities.

Authors:  Xia Zhang; Justin P Edwards; David M Mosser
Journal:  Methods Mol Biol       Date:  2009

8.  Tagging alcohols with cyclic carbonate: a versatile equivalent of (meth)acrylate for ring-opening polymerization.

Authors:  Russell C Pratt; Fredrik Nederberg; Robert M Waymouth; James L Hedrick
Journal:  Chem Commun (Camb)       Date:  2008-01-07       Impact factor: 6.222

9.  In vivo messenger RNA introduction into the central nervous system using polyplex nanomicelle.

Authors:  Satoshi Uchida; Keiji Itaka; Hirokuni Uchida; Kentaro Hayakawa; Toru Ogata; Takehiko Ishii; Shigeto Fukushima; Kensuke Osada; Kazunori Kataoka
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

10.  Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study.

Authors:  Hubert Kübler; Birgit Scheel; Ulrike Gnad-Vogt; Kurt Miller; Wolfgang Schultze-Seemann; Frank Vom Dorp; Giorgio Parmiani; Christian Hampel; Steffen Wedel; Lutz Trojan; Dieter Jocham; Tobias Maurer; Gerd Rippin; Mariola Fotin-Mleczek; Florian von der Mülbe; Jochen Probst; Ingmar Hoerr; Karl-Josef Kallen; Thomas Lander; Arnulf Stenzl
Journal:  J Immunother Cancer       Date:  2015-06-16       Impact factor: 13.751

View more
  47 in total

Review 1.  Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.

Authors:  Piotr S Kowalski; Arnab Rudra; Lei Miao; Daniel G Anderson
Journal:  Mol Ther       Date:  2019-02-19       Impact factor: 11.454

2.  A Potent Branched-Tail Lipid Nanoparticle Enables Multiplexed mRNA Delivery and Gene Editing In Vivo.

Authors:  Khalid A Hajj; Jilian R Melamed; Namit Chaudhary; Nicholas G Lamson; Rebecca L Ball; Saigopalakrishna S Yerneni; Kathryn A Whitehead
Journal:  Nano Lett       Date:  2020-06-09       Impact factor: 11.189

3.  Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy.

Authors:  Aaron J Wilk; Nancy Lynn-Benner Weidenbacher; Rosemary Vergara; Ole A W Haabeth; Ronald Levy; Robert M Waymouth; Paul A Wender; Catherine A Blish
Journal:  Blood Adv       Date:  2020-09-08

4.  Lipid-Modified Aminoglycosides for mRNA Delivery to the Liver.

Authors:  Xueliang Yu; Shuai Liu; Qiang Cheng; Tuo Wei; Sang Lee; Di Zhang; Daniel J Siegwart
Journal:  Adv Healthc Mater       Date:  2020-02-28       Impact factor: 9.933

Review 5.  Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications.

Authors:  Siddharth Patel; Avathamsa Athirasala; Paula P Menezes; N Ashwanikumar; Ting Zou; Gaurav Sahay; Luiz E Bertassoni
Journal:  Tissue Eng Part A       Date:  2018-06-07       Impact factor: 3.845

6.  Local Delivery of Ox40l, Cd80, and Cd86 mRNA Kindles Global Anticancer Immunity.

Authors:  Ole Audun Werner Haabeth; Timothy R Blake; Colin J McKinlay; Anders A Tveita; Adrienne Sallets; Robert M Waymouth; Paul A Wender; Ronald Levy
Journal:  Cancer Res       Date:  2019-01-28       Impact factor: 12.701

Review 7.  RNA delivery biomaterials for the treatment of genetic and rare diseases.

Authors:  Weiyu Zhao; Xucheng Hou; Olivia G Vick; Yizhou Dong
Journal:  Biomaterials       Date:  2019-06-20       Impact factor: 12.479

Review 8.  Nanoscale platforms for messenger RNA delivery.

Authors:  Bin Li; Xinfu Zhang; Yizhou Dong
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-05-04

9.  Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters.

Authors:  Colin J McKinlay; Nancy L Benner; Ole A Haabeth; Robert M Waymouth; Paul A Wender
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-11       Impact factor: 11.205

10.  A Dual-Function Antibiotic-Transporter Conjugate Exhibits Superior Activity in Sterilizing MRSA Biofilms and Killing Persister Cells.

Authors:  Alexandra Antonoplis; Xiaoyu Zang; Melanie A Huttner; Kelvin K L Chong; Yu B Lee; Julia Y Co; Manuel R Amieva; Kimberly A Kline; Paul A Wender; Lynette Cegelski
Journal:  J Am Chem Soc       Date:  2018-11-14       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.